Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CUPR research report →
Price Chart
About the company
Cuprina Holdings (Cayman) Limited is a Singaporean biotechnology and biomedical enterprise, primarily dedicated to pioneering and bringing to market advanced solutions for the management of persistent wounds. The company produces and supplies its flagship MEDIFLY brand, which features medical-grade sterile blowfly larvae bio-dressing products designed to function as an effective biological debridement tool for chronic wounds. Beyond its core wound care business, Cuprina also extends its operations into the broader health and beauty market, where it provides a range of cosmeceutical items.
- CEO
- Yong Qi Quek
- IPO
- 2025
- Employees
- 10
- HQ
- Singapore, CE, SG
Get TickerSpark's AI analysis on CUPR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $3.78M
- P/E
- -0.95
- PEG
- -0.01
- P/S
- 94.26
- P/B
- 0.96
- EV/EBITDA
- -0.43
- Div Yield
- 0.00%
- Gross Margin
- -32.51%
- Op Margin
- -10140.04%
- Net Margin
- -9714.94%
- ROE
- -84.78%
- ROIC
- -94.73%
Latest fiscal year · YoY change
- Revenue
- $49.89K+3.3%
- Gross Profit
- $-645+78.7%
- Op Income
- $-4,567,604
- Net Income
- $-4,673,447-199.5%
- EPS
- $-1.84-222.8%
- OCF Growth
- -639.0%
- FCF Growth
- -630.8%
- 52W High
- $14.80
- 52W Low
- $1.21
- 50D MA
- $1.93
- 200D MA
- $2.88
- Beta
- -0.38
- RSI (14)
- 30
- Avg Volume
- 115.59K
No earnings-call transcripts are available for CUPR yet.
- Free Float
- 34.3%
- Shares Outstanding
- 2.68M
- Float Shares
- 920.63K
of shares held by institutions
3 13F filers
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 18, 26 | CHAN Tat Jing | other | 0 |
| Mar 18, 26 | QUEK David Yong Qi | other | 0 |
| Mar 18, 26 | KOH Pee Keat | other | 0 |
| Mar 18, 26 | TEO Peng Kwang | other | 0 |
| Mar 18, 26 | RAINA Natasha Kaur | other | 0 |
| Mar 18, 26 | LEE Jimmy Peng Siew | other | 0 |
| Mar 18, 26 | NG Wei Chean | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CUPR coverage
Recent articles, reports, and earnings notes.
No research on CUPR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CUPR report →Cuprina (Nasdaq: CUPR) to Acquire EBITDA-Positive Seven-Clinic Singapore Healthcare Group
globenewswire.com · Oct 2
Cuprina Holdings (Cayman) Limited Announces Closing of Underwriter's Over-Allotment Option in Connection with Public Offering
globenewswire.com · Sep 29
Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) Shares Shorted: Short Interest Up 223.6% in September
defenseworld.net · Sep 28
Cuprina Holdings (Cayman) Limited Announces Closing of Public Offering
globenewswire.com · Sep 17
Super Copper Featured at OTC Markets' Virtual Investor Conference, Presentation Replay Now Available
accessnewswire.com · Aug 31
Cuprina Holdings Falls 22% After 112% Rally — Here's Why CUPR Stock Is Trending
feeds.benzinga.com · Jun 16
Cuprina Receives U.S. FDA 510(k) Clearance for MEDIFLY Maggots — the First U.S. Clearance for a Lucilia cuprina Maggot Debridement Product
globenewswire.com · Jun 15
Cuprina Holdings (Cayman) Limited Regains Compliance with Nasdaq Listing Requirements
globenewswire.com · Jun 12
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.